Intuitive Surgical insider trading
Every open-market purchase and sale by Intuitive Surgical's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Intuitive Surgical’s insiders pay?
From January 27, 2010 to November 12, 2019, 18 insiders reported 2 open-market purchases and 127 sales not made under a pre-set plan in Intuitive Surgical. Twelve months after each purchase was reported, the shares were +43.9% against the S&P 500 on average (median +43.9%), over 2 purchases with a full year of prices; 100% beat the index. After sales, the shares moved +8.3% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 15, 2010 into $18,380 by November 2, 2026, +3.9% a year. It held shares 7% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $13,686 (+2.0% a year), and held throughout $89,070 (+14.6%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Smith Lonnie M | Chairman of the Board | 0 | — | — | 28 | −1.8% (28) | November 12, 2019 |
| Duggan Robert W | Director | 0 | — | — | 20 | +7.6% (20) | May 4, 2011 |
| Morales Colin | GM & SVP Secondary Mkt Equip & | 0 | — | — | 13 | +13.3% (13) | February 8, 2017 |
| Halvorson Eric H | Director | 0 | — | — | 9 | −0.3% (9) | April 26, 2016 |
| Mcnamara Jerome J | EVP da Vinci WW Sales & Mktg | 0 | — | — | 9 | +5.2% (9) | October 24, 2011 |
| Levy Alan J | Director | 0 | — | — | 7 | +17.4% (7) | August 5, 2016 |
| Meltzer Mark J | SVP & General Counsel | 0 | — | — | 6 | +12.9% (6) | September 8, 2011 |
| Curet Myriam | EVP & Chief Medical Officer | 0 | — | — | 5 | +22.2% (5) | May 15, 2018 |
| Mohr Marshall | SVP & CFO | 0 | — | — | 5 | +11.7% (5) | July 22, 2011 |
| Stalk George Jr | Director | 0 | — | — | 5 | +24.3% (5) | May 4, 2016 |
| Johnson Amal M | Director | 2 | +43.9% (2) | 100% | 2 | +19.8% (2) | April 26, 2016 |
| Loop Floyd D Md | Director | 0 | — | — | 4 | +15.3% (4) | October 31, 2014 |
| Rosa David J. | Sr VP Emerging Procedures & Te | 0 | — | — | 4 | −7.7% (4) | October 29, 2012 |
| Samath Jamie | VP & Principal Accounting Offi | 0 | — | — | 4 | +6.5% (4) | March 14, 2016 |
| Brogna Salvatore | EVP - Product Operations | 0 | — | — | 2 | +44.3% (2) | June 3, 2016 |
| Grossman D Keith | Director | 0 | — | — | 2 | −20.1% (2) | April 23, 2010 |
| Castello Augusto V. | SVP Product Ops | 0 | — | — | 1 | +53.0% (1) | May 6, 2011 |
| Rubash Mark J | Director | 0 | — | — | 1 | +44.6% (1) | February 16, 2011 |
When several insiders traded Intuitive Surgical
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Intuitive Surgical in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 7 selling crowds, −3.0%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| March 31, 2016 | 4 selling | +8.4% | +12.9% | +10.1% |
| May 29, 2015 | 3 selling | +10.9% | +6.0% | +28.8% |
| November 28, 2014 | 4 selling | −4.1% | −6.6% | −2.3% |
| November 30, 2012 | 3 selling | −9.9% | −22.1% | −58.8% |
| January 31, 2011 | 5 selling | +3.4% | +21.0% | +38.2% |
| August 31, 2010 | 4 selling | −14.9% | −4.1% | +25.0% |
| April 30, 2010 | 8 selling | −2.2% | −27.8% | −20.1% |